These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6658556)

  • 21. [Psychophysiological aspect of the therapeutic use of pyridinolcarbamate].
    Sidorenko GI; Borisova GS; Sidorenko ER; Polonetskii LZ; Gelis LG
    Kardiologiia; 1983 Mar; 23(3):66-71. PubMed ID: 6855067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical and rheoencephalographical evaluation of prodectin in the treatment of cerebral arteriosclerosis].
    Wysocka-Bakowska MM
    Neurol Neurochir Pol; 1981; 15(4):431-36. PubMed ID: 7035991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effectiveness of pyridinolcarbamate in the overall treatment of infiltrative and cavernous-fibrous pulmonary tuberculosis].
    Makinskiĭ AI; Safarov RN; Fondaminskaia LD; Semenova AS; Fedotova NN
    Probl Tuberk; 1979 Jan; (1):26-30. PubMed ID: 368764
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of prodektin in the treatment of children with vasomotor rhinitis].
    Iaroslavtsev VA; Iaroslavtsev AK
    Vestn Otorinolaringol; 1987; (3):79. PubMed ID: 3617346
    [No Abstract]   [Full Text] [Related]  

  • 25. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P
    Minerva Cardioangiol; 1975 Apr; 23(4):261-9. PubMed ID: 1095958
    [No Abstract]   [Full Text] [Related]  

  • 26. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P
    J Pharm Sci; 1975 Jan; 64(1):261-9. PubMed ID: 1094102
    [No Abstract]   [Full Text] [Related]  

  • 27. [The pyridinolcarbamate-clofibrate combination in the treatment of vascular diseases in diabetics].
    Parodi FA; Caputo G
    Clin Ter; 1976 Dec; 79(6):571-81. PubMed ID: 1009761
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pyridinolcarbamate treatment of ischemic heart disease].
    Kuz'ko NV
    Vrach Delo; 1976 Jan; (1):27-30. PubMed ID: 1246850
    [No Abstract]   [Full Text] [Related]  

  • 29. Pyridinolcarbamate in the long-term treatment of ischaemic heart disease.
    Gulyás A; Szám I
    Ther Hung; 1976; 24(2):63-6. PubMed ID: 982341
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical evaluation of pyridinolcarbamate effect on patients with obliterating atherosclerosis (author's transl)].
    Roztocil K; Oliva I; Linhart J; Prerovský I; Modr Z
    Cas Lek Cesk; 1976 Aug; 115(33-34):1051-5. PubMed ID: 975177
    [No Abstract]   [Full Text] [Related]  

  • 31. [Changes of the electrophoretic tracing of the serum glycoproteins in diabetic subjects treated with pyridinolcarbamate].
    Notarbartolo A; Rini GB; Di Fede G
    Boll Soc Ital Cardiol; 1973; 18(4):379-83. PubMed ID: 4807078
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapeutic results with combination of pyridinolcarbamate and clofibrate in atherosclerotic patients].
    Valiensi M; Riboli E; Lombardi M
    Minerva Cardioangiol; 1976 Feb; 24(2):148-54. PubMed ID: 1256654
    [No Abstract]   [Full Text] [Related]  

  • 33. [Rheographic normalization in prediabetic subjects treated with pyridinolcarbamate].
    Furitano G; Paterna S; Di Pasquale P
    Minerva Med; 1978 May; 69(24):1655-9. PubMed ID: 662168
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of anginine on the state of the stomach and pancreas in diabetes mellitus].
    Semichastnova AG; Golubiatnikova GA; Permiakov NK; Titova GP; Bokaneva IA
    Sov Med; 1975 Oct; (10):36-42. PubMed ID: 1209326
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pathogenetic treatment of patients with disseminated neurodermatitis using the specific antikinin preparation parmidin].
    Grebennikov VA
    Sov Med; 1983; (1):44-7. PubMed ID: 6836389
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of Prodectin on various blood clotting factors].
    Czaplicki S; Ostrowska B; Sułek K
    Pol Tyg Lek; 1978 Sep; 33(39):1541-4. PubMed ID: 704456
    [No Abstract]   [Full Text] [Related]  

  • 37. [Evaluation of the effectiveness of anginine treatment of diabetic microangiopathies].
    Spesivtseva VG; Frenkel' VKh; Mamaeva GG; Sokolovskiĭ GA; Kukes VG
    Sov Med; 1975 Jul; (7):42-5. PubMed ID: 1216049
    [No Abstract]   [Full Text] [Related]  

  • 38. [Indications for using antikinin preparations and blood kinin system activators in the combined treatment of pulmonary tuberculosis].
    Makinskiĭ AI
    Probl Tuberk; 1981 Oct; (10):33-7. PubMed ID: 7312848
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of angioprotectors on the glomerular filtration rate and vascular permeability in diabetic angiopathies].
    Tirkina TN; Mirkhodzhaev AKh; Alekseev IuP; Ionushas BS; Kasymova SD
    Probl Endokrinol (Mosk); 1979; 25(4):11-6. PubMed ID: 471968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experimental study of the anti-inflammatory action of pyridinolcarbamate].
    Shvarts GIa; Liberman SS; Mashkovskiĭ MD; Berliand EA
    Farmakol Toksikol; 1975; 38(4):434-6. PubMed ID: 1213130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.